ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $121,719, the best ever quarter in terms of revenues in corporate history and an increase of 25% over the $97,424 recorded in the third quarter, fiscal year 2009. Net income after taxes in Q3FY10 was $8,013 resulting in fully diluted earnings per share (EPS) of $.29, up 24% and 26% respectively from the prior fiscal year third quarter net income after taxes of $6,439 and EPS of $.23 ($.46 as reported prior to the 2 for 1 split effective 4/18/2010). Gross profit on revenues for the current quarter was $61,630 resulting in a margin for gross profit on revenues of 51%, versus the $49,261, also 51%, reported for the prior fiscal year third quarter. Revenue per patient for the third quarter of the current fiscal year was $82.70, an increase of 7% over the $77.61 reported for the same quarter of the prior fiscal year. The number of patients served increased 17% to 1,460 in the current quarter from the prior year third quarter total of 1,246. Esoteric business for the Company was 57% of revenues for the third quarter of the current fiscal year. The Company further noted that Days Sales Outstanding (DSO) were 94 days compared to the prior fiscal year same period when the DSO were 95 days.
